Company Filing History:
Years Active: 2014
Title: Nikhil Krishnamurthy Hebbar: Innovator in Cancer Treatment
Introduction
Nikhil Krishnamurthy Hebbar is a notable inventor based in Mumbai, India. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on enhancing the efficacy of radiotherapy, particularly for head and neck cancer.
Latest Patents
Nikhil holds a patent for "Pyrrolidine-substituted flavones as radio-sensitizers for use in the treatment of cancer." This invention relates to a combination that exhibits a synergistic effect in cancer treatment. The combination includes radiation and at least one cyclin-dependent kinase (CDK) inhibitor selected from specific compounds. The method involves administering a therapeutically effective amount of this combination to patients in need, thereby enhancing the effectiveness of radiotherapy.
Career Highlights
Nikhil is currently associated with Piramal Enterprises Limited, where he continues to work on groundbreaking research in the pharmaceutical sector. His dedication to improving cancer treatment options has positioned him as a valuable asset in the field.
Collaborations
Nikhil collaborates with talented professionals, including Maggie Rathos and Kalpana Sanjay Joshi, who contribute to his innovative projects and research initiatives.
Conclusion
Nikhil Krishnamurthy Hebbar's contributions to cancer treatment through his patent and ongoing work at Piramal Enterprises Limited highlight his commitment to advancing medical science. His innovative approach has the potential to significantly impact the lives of cancer patients.